TRANQ Research Act of 2023
The TRANQ Research Act of 2023 directs the National Institute of Standards and Technology (NIST) to fund research on detecting xylazine - a tranquilizer sometimes found in illicit drugs - and other emerging substances. NIST must develop faster testing methods, create public data tools for identifying these drugs, and collaborate with universities, nonprofits, and federal labs to improve detection capabilities and safety practices. The bill requires NIST to report on its progress to Congress within one year. This research initiative aims to enhance scientific tools for drug analysis without imposing new regulations or affecting the public directly.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2023
Committee Review
Floor Vote
President
Introduced Apr 25, 2023
Last action Dec 13, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
2
Committee
3
Dec 13, 2023
Upper · Passed
Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
upper
May 10, 2023
Upper · Passed
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
upper
Apr 25, 2023
Committee
Read twice and referred to the Committee on Commerce, Science, and Transportation.
upper
Apr 25, 2023
Introduced
Introduced in Senate
upper
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1280
Scope: US
Hi! I can help you understand S 1280. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline